Brief: Apollomics Highlights Clinical Progress And Reports Full Year 2023 Results

Apollomics

28/03/2024 11:13

March 28 (Reuters) - Apollomics Inc  APLM.O :
    * APOLLOMICS HIGHLIGHTS CLINICAL PROGRESS AND REPORTS FULL
YEAR
2023 FINANCIAL RESULTS
    * COMPLETED PATIENT ENROLLMENT FOR UPROLESELAN (APL-106)
PHASE 3
BRIDGING STUDY IN CHINA - TOPLINE DATA EXPECTED IN FIRST HALF OF
2025
    * CASH RUNWAY THROUGH Q1 2025

Source text for Eikon:  ID:nGNX8lyLrg 
Further company coverage:  APLM.O 

 ((Reuters.Briefs@thomsonreuters.com;))